CLOSE X

CREM056i-BR39-1

** The karyotype for this cell line may contain a non-clonal finding known to be recurrent in pluripotent stem cells. Please see the karyotype report in the currently distributing lot(s) ``Product Information & Testing`` PDF(s) linked below for more information.
Cell Line Alias BR-SP-39-1
Cell Type Human iPS
Disease Sickle cell anemia SS
Diagnosis Information Diagnosis of Sickle Cell Anemia SS was physician reported
Genetic Alteration/Mutation HBB(E6V)
Genetic Alteration/Mutation Information A>T mutation in beta globin gene
Sex Male
Age at Collection 22 Years
Ethnicity Latino > South American
Ethnicity Information Physician reported; Country of Origin: Brazil
Genetically Related Cell Lines  
Reprogramming Method Viral transfection (Lentivirus: Oct4, Klf4, Sox2, cMyc)
Tissue Origin Blood
Provider Boston University and Boston Medical Center's Center for Regenerative Medicine (CReM) - Dr. Steinberg, Dr. Mostoslavsky, Dr. Murphy
dbGaP Data  
hPSCReg ID  
NIH Approval  
Pub Med Abstract  
Collection(s) NHLBI Next Gen - Sickle Cell Anemia (Dr. Steinberg, Dr. Mostoslavsky, Dr. Murphy, Boston University and Boston Medical Center's Center for Regenerative Medicine)
Have you received this cell line previously? Yes No Why we ask
Quantity: Learn about our volume discounts

Current Lot Information

Lot Number Culture Platform Lot Description Passage Number Banked By Protocol Product Information & Testing
WB67703 mTeSR Plus/Matrigel   14 WiCell WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF

Historical Lot Information

Lot Number Culture Platform Lot Description Banked By Protocol Product Information & Testing
DB66775 mTeSR1/Matrigel   Provider WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF